CELL BIOCHEMISTRY AND FUNCTION is a prominent journal dedicated to disseminating high-quality research in the fields of biochemistry, cell biology, and clinical biochemistry. Published by Wiley, this journal has maintained an esteemed reputation since its inception in 1983, bridging decades of scientific advancements and contributions until 2024. With ISSN 0263-6484 and E-ISSN 1099-0844, it serves as a vital resource for researchers, professionals, and students. The journal is classified in quartiles Q2 and Q3 across various categories in the 2023 rankings, showcasing its impact and significance within the academic community. Highlighting essential studies in medicinal biochemistry and cellular functionalities, CELL BIOCHEMISTRY AND FUNCTION not only presents cutting-edge research but also encourages interdisciplinary collaboration, thereby advancing the understanding of biochemical processes that underlie living systems. With no open access currently available, readers are encouraged to access articles through institutional subscriptions or individual purchases, ensuring exclusive engagement with the latest scientific findings in this dynamic field.

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

MOLECULAR ASPECTS OF MEDICINE is a premier journal published by Elsevier, focusing on groundbreaking research in the fields of biochemistry, molecular biology, and medicine. With an impressive impact factor and ranking within the top quartile across multiple categories, including Q1 in Biochemistry, Clinical Biochemistry, and Molecular Medicine, it serves as an essential platform for sharing innovative findings that advance our understanding of molecular mechanisms in health and disease. The journal, which has been in publication since 1976, provides a diverse range of articles, addressing both fundamental and applied aspects of molecular medicine, thus appealing to a broad audience of researchers, professionals, and students. While MOLECULAR ASPECTS OF MEDICINE does not currently offer Open Access options, it remains a vital resource for accessing high-quality, peer-reviewed scholarly works that significantly contribute to the advancement of biomedical research.

AMINO ACIDS is a distinguished journal published by Springer Wien, specializing in the dynamic field of biochemistry, with a particular focus on the role of amino acids in biological processes. Since its inception in 1991, this journal has become a crucial resource for researchers and professionals, contributing valuable insights into the biochemical makeup and clinical applications of amino acids. With a commendable impact factor reflecting its high-quality publications, AMINO ACIDS consistently ranks in the Q2 category across biochemistry and organic chemistry domains as of 2023, demonstrating its significant influence within the scholarly community. The journal is indexed in Scopus and maintains strong rankings—59th in Organic Chemistry and 43rd in Clinical Biochemistry—highlighting its relevance and rigorous peer-review standards. While it currently does not offer open access options, the journal remains dedicated to advancing knowledge in both fundamental and applied biochemistry, making it an essential platform for disseminating cutting-edge research findings. For any academic seeking to explore the complexities of amino acids, AMINO ACIDS serves as an invaluable reference.

Journal of Inflammation-London, published by BMC, is a premier open access journal dedicated to advancing the understanding of inflammation, a critical process underlying numerous diseases including autoimmune disorders, cancer, and cardiovascular conditions. With its inception in 2004, the journal has consistently delivered high-quality research that bridges basic science and clinical applications, maintaining a significant place in the academic community. It holds impressive rankings within the Q2 category for both Cell Biology and Clinical Biochemistry, reflecting its impactful contributions to these fields, where it ranks in the 73rd and 64th percentiles respectively. The journal is committed to open access principles, ensuring that all published articles are freely available to researchers, practitioners, and the global community, thereby fostering collaboration and innovation. Located in the United Kingdom, the journal continues to attract submissions from prominent researchers and institutions worldwide, solidifying its status as an essential resource for the latest developments in inflammation research.

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

Journal of Medical Biochemistry is a distinguished peer-reviewed journal published by the SOC MEDICAL BIOCHEMISTS SERBIA, focusing on the significant intersection of biochemistry and medicine. With an e-ISSN of 1452-8266, this Open Access journal has been enriching the academic community since 2007, providing vital insights and research findings that advance the field of medical biochemistry. Based in Belgrade, Serbia, the journal plays a pivotal role in disseminating contemporary research, highlighted by its impressive standings in the 2023 quartile rankings, featuring Q2 in Medical Biochemistry and Q3 in Clinical Biochemistry. The journal is recognized in Scopus with rankings that position it within the discerning area of medical biochemistry and clinical biochemistry, attesting to its influence and relevance. By promoting innovative research and facilitating an open exchange of scientific ideas, the Journal of Medical Biochemistry is a crucial resource for researchers, professionals, and students dedicated to uncovering the biochemical underpinnings essential to improving human health.

BMB Reports is a distinguished open-access journal published by the Korean Society of Biochemistry & Molecular Biology since 2008, making significant contributions to the fields of biochemistry, molecular biology, and medicine. With a current impact factor that positions it in the Q2 category for Biochemistry and Q1 for Miscellaneous Medicine, this journal supports a wide dissemination of high-quality research findings, fostering robust dialogue among researchers, professionals, and students alike. Based in Seoul, South Korea, BMB Reports aims to publish innovative studies that advance our understanding of biochemical and molecular processes, thus shaping the future of health and medicine. The journal's commitment to open access enhances the visibility of its articles, allowing for greater accessibility and engagement in the scientific community. With notable rankings in both the Biochemistry and Molecular Biology categories, BMB Reports stands as a vital resource for those seeking to stay at the forefront of research in these rapidly evolving disciplines.

The Indian Journal of Clinical Biochemistry, published by SPRINGER INDIA, serves as a pivotal platform for researchers and professionals in the field of clinical biochemistry. With an ISSN of 0970-1915 and E-ISSN 0974-0422, this esteemed journal has been disseminating high-quality research since its inception in 1986. As a Q3 ranked journal in Clinical Biochemistry according to the 2023 category quartiles, it occupies a significant position within the realm of biochemistry, genetics, and molecular biology—ranked #61 out of 117 in Scopus. The journal's scope emphasizes the advancement of knowledge and practices in clinical diagnostics, aiming to bridge the gap between laboratory research and clinical application. Positioned in the vibrant academic landscape of India, the Indian Journal of Clinical Biochemistry is a crucial resource for students, researchers, and professionals seeking to stay abreast of the latest trends and innovations in the field, thus fostering the development of clinical biochemistry both nationally and globally.

Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.